LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S.NOVA-2 trial to enroll approximately 460 patientsPrimary ...

LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...

Huntington Beach, California - March 24, 2026 - PRESSADVANTAGE - Moment of Clarity has released a detailed educational ...

I remember the first time I heard the time "treatment resistant." It was from a friend as they shared with me their mental health story. As this conversation took place some years before my schooling ...

Depression, schizophrenia and other mental health conditions affect 1 in 4 people in their lifetime, but the mechanisms underlying these conditions are poorly understood. New research led by ...

Around 8% of human DNA is made up of genetic sequences acquired from ancient viruses. These sequences, known as human endogenous retroviruses (or Hervs), date back hundreds of thousands to millions of ...

Schizophrenia affects 1% of the global population and is caused by a complex interplay between at least 280 genes and ...

Psychiatric disorders like schizophrenia, bipolar disorder, and depression have a strong genetic signature. Through advanced transcriptome-wide association studies (TWAS), researchers can identify ...

Scientists have long studied the role of dopamine, a chemical in the brain that helps control learning and movement, in order ...